
|Articles|December 15, 2003
Ophthalmic market poised for upswing
Marblehead, MA-As the year draws to a close, U.S. ophthalmologists are taking an assessment of where things stand in their practices and in the world around them. Many are finding comfort in the knowledge that the ophthalmic market continues to hold its own in an uncertain economic climate, said Kenneth P. Taylor in an independent analysis of the vision-care sector.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Regeneron receives another CRL for its Eylea 8 mg
2
Eli Lilly to acquire Adverum Biotechnologies
3
Anti-VEGF innovations in retinal disease: From molecules to medicine
4
Topcon Healthcare seeks to advance company through acquisition and new investment
5


















































.png)


